About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in San Francisco | 46 Studies

Clinical Trials Brain CancerSan Francisco

Brain Cancer Clinical Trials in San Francisco

Find 46 clinical trials for brain cancer near San Francisco, California. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in San Francisco

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 46 trials

RecruitingSonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMThe brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB). This physical barrier is located at the level of the blood vessel walls.NCT05902169·Phoenix, Arizona and 55 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedHyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With GlioblastomaThe purpose of this study is to evaluate whether new metabolic imaging will be useful to physicians and patients with glioblastoma for making treatment decisions and seeing how…NCT04019002·San Francisco, California

CompletedConvection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaThis is a single-arm, open-label, multicenter study in approximately 52 adults with primary (de novo) GB that has recurred or progressed (first or second recurrence, including…NCT02858895·San Francisco, California and 6 others

TerminatedVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMThis is an adaptive design, randomized controlled, Phase 3 clinical trial in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS), previously treated with surgery (if…NCT03149575·Los Angeles, California and 4 others

RecruitingThe RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited functioning performance at…NCT06146725·San Francisco, California and 7 others

RecruitingThe SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients.NCT06118723·San Francisco, California and 7 others

CompletedRamucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: Monoclonal antibodies, such as ramucirumab and anti-PDGFR alpha monoclonal antibody IMC-3G3 (Olaratumab), can block tumor growth in different ways.NCT00895180·Birmingham, Alabama and 10 others

Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

CompletedIL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaThis Phase 1 study in patients with newly diagnosed malignant glioma is designed to determine the highest dose of IL13-PE38QQR that can be safely administered by Convection…NCT00089427·San Francisco, California and 5 others

CompletedErlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaPhase I/II trial to study the effectiveness of erlotinib in treating patients who have recurrent malignant glioma or recurrent or progressive meningioma.NCT00045110·Los Angeles, California and 6 others

CompletedErlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaErlotinib and temsirolimus and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00112736·Los Angeles, California and 7 others

TerminatedTumor Treating Fields With Chemoradiation in Newly Diagnosed GBMThe study is an open-label pilot study in newly diagnosed glioblastoma patients following surgery.NCT03705351·San Francisco, California and 1 other

RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss.NCT06810544·Scottsdale, Arizona and 14 others

CompletedFluoroethyltyrosine for Evaluation of Intracranial NeoplasmsThis phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have come back.NCT04044937·San Francisco, California

CompletedPazopanib in Treating Patients With Recurrent GlioblastomaThis phase II trial is studying the side effects and how well pazopanib works in treating patients with recurrent glioblastoma.NCT00459381·Los Angeles, California and 8 others

TerminatedA Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGThis research study involves an investigational product: Ad-RTS-hIL-12 given with veledimex for production of human IL-12.NCT03330197·San Francisco, California and 2 others

CompletedSorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaThis phase I/II trial is studying the side effects and best dose of erlotinib, tipifarnib, and temsirolimus when given together with sorafenib and to see how well they work in…NCT00335764·Los Angeles, California and 6 others

CompletedPhase II Study of BKM120 for Subjects With Recurrent GlioblastomaBKM120 is a newly discovered drug that has been used in other research studies.NCT01339052·Los Angeles, California and 6 others

Active not recruitingStudy of DSP-0390 in Patients With Recurrent High-Grade GliomaThis is a study of DSP-0390 in patients with recurrent high grade glioma.NCT05023551·San Francisco, California and 8 others

CompletedFR901228 in Treating Patients With Recurrent High-Grade GliomasThis phase I/II trial is studying the side effects and best dose of FR901228 and to see how well it works in treating patients with recurrent high-grade gliomas.NCT00085540·Los Angeles, California and 7 others

Page 1 of 3Next

Other Conditions in San Francisco

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia